Antidiuresis: A new concept in managing female daytime urinary incontinence

BJU International

Volumn 93, Issue 7, 2004, Pages 996-1000

  Robinson, D ^a   Cardozo, L ^a   Akeson, M ^b   Hvistendahl, G ^c   Riis, A ^c   Norgaard, J P ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Dept of Obstetrics and Gynecology   (Sweden)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Ferring Pharmaceuticals AS   (Denmark)

Author keywords

Daytime; Desmopressin; Urinary incontinence; Women

Indexed keywords

DESMOPRESSIN; ARGIPRESSIN[1 DEAMINO]; URINARY TRACT AGENT;

ABDOMINAL DISCOMFORT; ADULT; AGED; ANTIDIURESIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALAISE; MIXED INCONTINENCE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STRESS INCONTINENCE; TREATMENT OUTCOME; URGE INCONTINENCE; WEIGHT GAIN; ARTICLE; INTRANASAL DRUG ADMINISTRATION; MIDDLE AGED; URINE INCONTINENCE;

ADMINISTRATION, INTRANASAL; ADULT; AGED; AGED, 80 AND OVER; CROSS-OVER STUDIES; DEAMINO ARGININE VASOPRESSIN; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; RENAL AGENTS; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 2542519182     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2004.04768.x     Document Type: Conference Paper

References (13)

1. Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function. Report from the standardisation committee of the International Continence Society. Neurourol Urodynam 2002; 21: 167-78
2. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynaecol 1997; 104: 1374-9
3. Hannestad YS, Rortveit G, Sandvik H, Hunskar S. A community-based epidemiological survey of female urinary incontinence: The Norwegian EPINCONT Study. J Clin Epidem 2000; 53: 1150-7
4. Smith CP, Chancellor MB. Genitourinary tract patent update. Exp Opin Ther Patents 2001; 11: 17-31
5. Kelleher CJ, Cardozo LD, Khullar V, Salvatore S. A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance. Br J Obstet Gynaecol 1997; 104: 988-93
6. Hilton P, Hertogs K, Stanton SL. The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatry 1983; 46: 854-5
7. Sutherst JR, Brown MC, Richmond D. Analysis of the pattern of urine loss in women with incontinence as measured by weighing perineal pads. Br J Urol 1986; 58: 273-8
8. Mattiasson A, Abrams P, Van Kerrbroeck P, Walter S, Weiss J. Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 2002; 89: 855-62
9. Miller K, Atkin B, Moody ML. Drug therapy for nocturnal enuresis. Drugs 1992; 44: 47
10. Robson WL, Norgaard JP, Leung AK. Hyponatraemia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 1996; 155: 959
11. Schwab M, Ruder H. Hypernatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing. Eur J Pediatr 1997; 156: 668
12. Wein A, Abrams P. Statement from the First International Consultation on Nocturia: reaching for a consensus. BJU Int 2002; 90 (Suppl. 3): 37
13. Meyhoff HH, Gerstenberg TC, Nordling J. Placebo. The drug of choice in female motor urge incontinence. Br J Urol 1983; 55: 34-7